Back to Polls Poll Results

Poll Results


Which one of the following innovations do you think is most likely in 2016?


Much more accurate continuous glucose sensing in general use






Closed loop sensing and insulin pumps (e.g., Bionic Pancreas) in widespread trials






New drugs other than insulin widely used in type 1 diabetes




A breakthrough in islet cell transplantation






A breakthrough in halting autoimmunity






A breakthrough in finding the cause of type 1






Something else






No real change from today






Total votes: 28


Which one of the following innovations do you think is most likely in 2016?

Poll dates: December 30, 2015 - January 6, 2016
Total Votes: 28

Doctors, scientists, and engineers in academia, government, and industry are working hard to develop a cure for type 1 diabetes, to find ways to prevent it, and to develop better tools to improve treatment. Throughout the year, we report on the progress of this work through our weekly What's New email newsletter. To close out 2015, we thought we'd ask our readers what they thought 2016 would bring.

We've run similar polls in December 2006, December 2007, December 2008, December 2009, December 2010, December 2011, December 2012, December 2013, and December 2014.

[Return to the current poll]

  Back to Polls Return to the Top of This Page

Last Updated: Wednesday January 04, 2017 20:26:09
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.